Success Metrics

Clinical Success Rate
89.5%

Based on 17 completed trials

Completion Rate
89%(17/19)
Active Trials
4(14%)
Results Posted
12%(2 trials)
Terminated
2(7%)

Phase Distribution

Ph phase_2
5
17%
Ph early_phase_1
2
7%
Ph phase_1
2
7%
Ph phase_4
2
7%
Ph not_applicable
16
55%
Ph phase_3
1
3%

Phase Distribution

4

Early Stage

5

Mid Stage

3

Late Stage

Phase Distribution28 total trials
Early Phase 1First-in-human
2(7.1%)
Phase 1Safety & dosage
2(7.1%)
Phase 2Efficacy & side effects
5(17.9%)
Phase 3Large-scale testing
1(3.6%)
Phase 4Post-market surveillance
2(7.1%)
N/ANon-phased studies
16(57.1%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

77.3%

17 of 22 finished

Non-Completion Rate

22.7%

5 ended early

Currently Active

4

trials recruiting

Total Trials

29

all time

Status Distribution
Active(4)
Completed(17)
Terminated(5)
Other(3)

Detailed Status

Completed17
Recruiting4
unknown3
Withdrawn3
Terminated2

Development Timeline

Analytics

Development Status

Total Trials
29
Active
4
Success Rate
89.5%
Most Advanced
Phase 4

Trials by Phase

Early Phase 12 (7.1%)
Phase 12 (7.1%)
Phase 25 (17.9%)
Phase 31 (3.6%)
Phase 42 (7.1%)
N/A16 (57.1%)

Trials by Status

recruiting414%
unknown310%
completed1759%
terminated27%
withdrawn310%

Recent Activity

Clinical Trials (29)

Showing 20 of 29 trialsScroll for more
NCT05412160Not Applicable

Improving Quality of Life and Daily Life Activities With Bioarginine in Patients With COPD

Completed
NCT05306925Not Applicable

An Exploratory Study of Arginine Supplementation and the Postoperative Immune REsponse

Recruiting
NCT00497380Not Applicable

Arginine Feeding: a Novel Strategy to Improve Protein Metabolism in Cancer and the Response to Surgery

Completed
NCT06328686Early Phase 1

Arginine and Whole Brain Radiation Therapy for the Treatment of Patients With Brain Metastases

Recruiting
NCT06483737Not Applicable

Human Albumin Infusion in Liver Cirrhosis and Overt Hepatic Encephalopathy (HACHE)

Recruiting
NCT02447874Phase 1

Arginine Therapy for the Treatment of Pain in Children With Sickle Cell Disease

Recruiting
NCT04828278Not Applicable

Nutrition21 Study 1

Completed
NCT06135792Not Applicable

The Effect of Arginine on Biofilm Composition, Architecture and Metabolism

Completed
NCT06216262Not Applicable

Evaluation of the Effectiveness of Home-Use Desensitizing Agents on Dentin Hypersensitivity

Completed
NCT04786873Phase 3

A Research Study of How Well Macimorelin Works to Find Out if Children Have a Lack of Growth Hormone and How Safe it is

Completed
NCT02499926Not Applicable

Lysine Oxidation in Response to Arginine Supplementation

Completed
NCT05299112Not Applicable

An Exploratory Study of Increased Preterm Arginine INTake (PAINT18)

Unknown
NCT04079010Not Applicable

The Effect of Blood Flow Restriction With and Without Arginine on Physical Performance and Growth Hormone

Completed
NCT02809170Not Applicable

The Effect of Arginine and Citrulline Supplementation on Endothelial Dysfunction in Mitochondrial Diseases

Completed
NCT02882373Phase 2

Arginine in Treating Patients With Anti-VEGF Induced Kidney Injury

Withdrawn
NCT02751437Not Applicable

Preterm Arginine INTake Study

Completed
NCT02440061Phase 1

Ghrelin and Beta Cell Function in Diabetes

Withdrawn
NCT00345605Phase 2

Arginine and Buphenyl in Patients With Argininosuccinic Aciduria (ASA), a Urea Cycle Disorder

Completed
NCT03180775Not Applicable

Effects of Dietary Amino Acids on Serum and Macrophage Atherogenicity

Unknown
NCT00513617Phase 2

Effectiveness of Arginine as a Treatment for Sickle Cell Anemia

Completed

Drug Details

Intervention Type
DRUG
Total Trials
29